Heart rate lowering treatment leads to a reduction in vulnerable plaque features in atherosclerotic rabbits - Wikidata - wikimedia - TriplyDB

Heart rate lowering treatment leads to a reduction in vulnerable plaque features in atherosclerotic rabbits

Heart rate lowering treatment leads to a reduction in vulnerable plaque features in atherosclerotic rabbits

http://www.wikidata.org/entity/Q36412437

about

The effect of the heart rate lowering drug Ivabradine on hemodynamics in atherosclerotic mice Using imaging photoplethysmography for heart rate estimation in non-human primates

P2860

Q58726558-4FDD2658-2E7C-4208-A7A4-69795ABF7D7C Q58782416-8CDDBA94-C857-46F3-A501-83146C1577C2

P2860

Heart rate lowering treatment leads to a reduction in vulnerable plaque features in atherosclerotic rabbits

http://www.wikidata.org/entity/Q36412437

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Heart rate lowering treatment ...... res in atherosclerotic rabbits

@ast

Heart rate lowering treatment ...... res in atherosclerotic rabbits

@en

type

label

Heart rate lowering treatment ...... res in atherosclerotic rabbits

@ast

Heart rate lowering treatment ...... res in atherosclerotic rabbits

@en

prefLabel

Heart rate lowering treatment ...... res in atherosclerotic rabbits

@ast

Heart rate lowering treatment ...... res in atherosclerotic rabbits

@en

P1433

Q36412437-F56DA63D-42AA-487B-BB95-2046F04B7D7D

P1476

Q36412437-1DC48F65-4D3A-46F2-BB3D-68FF0B484822

P2093

Q36412437-19B4EE71-2F5F-4D92-BFD0-1F39FBD44D08

Q36412437-311F5A5A-47C1-4DA3-A906-838561B8A2D0

Q36412437-49498A87-79A6-4C12-9D8C-9ACB9A9A6A1D

Q36412437-B92E0267-9FDB-413F-8C6A-70F7A60F1925

Q36412437-BDCFA307-B281-4510-AC4B-F57C37E8F296

Q36412437-DDCD29EA-72D5-477E-9F6B-819F89B553DD

Q36412437-E71F2BF8-F5F0-4183-AB80-61695B849018

Q36412437-FF477EE3-A65D-4157-9312-29D834DFA504

P2860

Q36412437-01064DA0-4F60-4AB6-80EB-4310DBF1C1A4

Q36412437-0D4D2B1C-82F4-4D3A-BC92-99A49DF487F0

Q36412437-0E3290D2-17CB-4050-9CF9-96AE3F8E6DC8

Q36412437-1E476356-3306-4C52-B9BC-F30401B534DB

Q36412437-2034ECCA-44F9-4F0F-B504-1ADAFBC5CF05

Q36412437-21AAF215-183F-47E0-86E7-11C0FED0B56C

Q36412437-26C1BAC6-36EE-4617-AA8D-6DFF49FCB373

Q36412437-35764FB4-A768-4BEE-8E97-D32745F16DFF

Q36412437-3B15372F-D318-4BEB-8A6A-354F1C3AA43D

Q36412437-406E826D-2716-4C1E-99FF-70A41648FB00

P304

Q36412437-977FBDFA-F6B7-45D7-A639-4CCC2E15849A

P31

Q36412437-26C18A80-7FC3-4935-A697-B17F4514154D

P356

Q36412437-F9F32C4D-6C38-4887-9C3C-75133FCD912D

P407

Q36412437-CEC93300-EB6F-413C-8ABB-DD25EE081C7F

P433

Q36412437-CA4BA06E-2E12-4EDC-97FF-D8F965D3C289

P478

Q36412437-D5BF6C47-C94D-4096-B0EB-2231A849E0EB

P50

Q36412437-4F8BA51D-4AB2-4C89-9710-C8C6801D94AC

Q36412437-A163B130-34EA-4A52-804C-86122775B1FE

Q36412437-D3B84955-B85B-451C-AF0F-9276E5EBAB00

P577

Q36412437-02008536-FD47-48D4-A7A8-C1C2D1B19C61

P698

Q36412437-804FA6FE-70A5-4F92-B65E-E3A3463A3850

P921

Q36412437-8BB7C56E-4D81-4F1D-9339-2F6623D5F394

P932

Q36412437-523B4D03-5248-4C0A-B638-E23D4CF481D3

P356

JOURNAL.PONE.0179024

P1433

P1476

Heart rate lowering treatment ...... res in atherosclerotic rabbits

@en

P2093

Arnold P G Hoeks

http://www.w3.org/2001/XMLSchema#string

Evelien Hermeling

http://www.w3.org/2001/XMLSchema#string

Harry Struijker-Boudier

http://www.w3.org/2001/XMLSchema#string

Joachim E Wildberger

http://www.w3.org/2001/XMLSchema#string

Julie Salzmann

http://www.w3.org/2001/XMLSchema#string

Jérôme Roussel

http://www.w3.org/2001/XMLSchema#string

Raf H M van Hoof

http://www.w3.org/2001/XMLSchema#string

Sylvia Heeneman

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment of local pulse wave velocity in arteries using 2D distension waveforms

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

MR in mouse models of cardiac disease.

Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model.

Reproducibility of black blood dynamic contrast-enhanced magnetic resonance imaging in aortic plaques of atherosclerotic rabbits.

Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells.

Neovascularization in human atherosclerosis.

Effects of isoflurane, ketamine-xylazine and a combination of medetomidine, midazolam and fentanyl on physiological variables continuously measured by telemetry in Wistar rats

Carotid artery stenosis: grayscale and Doppler ultrasound diagnosis--Society of Radiologists in Ultrasound consensus conference.

Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study.

P304

e0179024

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0179024

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Judith C Sluimer

Mat J A P Daemen

P577

2017-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28640847

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

5480870

http://www.w3.org/2001/XMLSchema#string